Application no. and date | 17781030.6 (espacenet) (Federated) (European Patent Register), 20170922 | Patent/reg. no. and date | DK/EP 3516060, 20210721 | Publication date | 20190731 | Priority no. and date | GB 201616202, 20160923 | EP pub. no. and date |
EP 3516060 20190731 | Effective date | | Applicant/owner | Laboratoires THEA, 12, rue Louis Blériot Z.I. du Brezet 63100 Clermont-Ferrand, FR | Applicant ref. no. | 170192 | Inventor | TURUNEN, Janne Juha, c/o ProQR Therapeutics II B.V. Zernikedreef 9
2333 CK Leiden, NL, VAN DIEPEN, Hester Catharina, c/o ProQR Therapeutics II B.V. Zernikedreef 9
2333 CK Leiden, NL, CHAN, Hee Lam, c/o ProQR Therapeutics II B.V. Zernikedreef 9
2333 CK Leiden, NL | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/7088 (2006.01) , A61K 31/712 (2006.01) , A61P 27/02 (2006.01) , C12N 15/113 (2010.01) | Title | ANTISENSE-OLIGONUKLEOTIDER TIL BEHANDLING AF ØJENSYGDOM | Int. application no. | EP2017074133 | Int. publication no. | WO2018055134 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|